Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for Decompensated Cirrhosis
NCT05224960Phase 2Recruiting
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Jun 2024
- Primary completion
- Jun 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord derived mesenchymal stem cells in decompensated cirrhosis, sponsored by The Fifth Medical Center of the PLA General Hospital. Started Jun 2024; status: recruiting.
02
Drugs
human umbilical cord derived mesenchymal stem cells
03
Conditions
decompensated cirrhosis
Beyond the preview
Go deeper on NCT05224960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05224960.